Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Audentes Therapeutics, Inc. (BOLD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/21/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – BOLD, INST, THOR |
12/16/2019 |
GN
| TECD, TIF, BOLD, and WLH SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
12/10/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – INST, AKS, BOLD, SORL |
12/02/2019 |
GN
| Audentes Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Audentes Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BOLD |
10/16/2018 |
GN
| Report: Developing Opportunities within The Ensign Group, Forterra, Inc., Audentes Therapeutics, Assembly Biosciences, Capital Senior Living, and Myomo — Future Expectations, Projections Moving into 2018 |
08/17/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within AgroFresh Solutions, SMART SAND INC, Advantage Oil & Gas, Abeona Therapeutics, B. Riley Financial, and Audentes Therapeutics — New Research Emphasizes Economic Growth |
03/07/2018 |
GN
| New Research: Key Drivers of Growth for Entergy, CarMax, Verifone, Audentes Therapeutics, EZCORP, and Cabot Microelectronics — Factors of Influence, Major Initiatives and Sustained Production |
|
|